BOC Sciences delivers high-quality calcium hydroxylapatite (CaHA) filler formulation and production services that support the expanding demands of the medical and aesthetic sectors. Our delivery of CaHA-based fillers benefits from cutting-edge facilities and formulation knowledge through a streamlined process that includes raw material preparation, microsphere engineering, carrier matrix optimization, and final product refinement. BOC Sciences dedicates itself to precision and customization to ensure every formulation reaches our clients' specific performance and application objectives. Our extensive expertise in material science and biocompatible systems enables us to support partners in speeding up their product development while enhancing their market competitiveness worldwide.
CaHA Filler (Calcium Hydroxylapatite Filler) represents a popular injectable dermal filler for cosmetic and medical applications. CaHA serves as the primary ingredient of the filler because it exists naturally within human bones and teeth which ensures high biocompatibility. CaHA takes the form of a filler by being combined with a gel matrix typically made from substances such as carboxymethylcellulose (CMC) or hyaluronic acid. The filler delivers instant wrinkle smoothing and volume restoration while simultaneously triggering natural collagen production that leads to lasting skin enhancement. CaHA Filler finds widespread use in facial wrinkle treatments as well as volume restoration and contouring because it delivers results that are both long-lasting and natural-looking. The product delivers fast volume enhancement and encourages collagen production which results in both quick visual improvements and sustained benefits making it widely chosen by those who want a secure and efficient facial rejuvenation treatment.
We supply medical-grade calcium hydroxylapatite with strict purity control to ensure biocompatibility and product safety.
Our formulations offer uniform CaHA microsphere size, optimizing injectability and smooth, natural tissue integration.
We offer flexible carrier options, including CMC and hyaluronic acid-based gels, to meet specific rheological performance needs and enhance overall product effectiveness.
Our formulations are designed to maximize long-term collagen regeneration for durable wrinkle reduction and skin texture improvement.
Balanced gel viscosity and elasticity ensure easy injection, precise shaping, and stable in vivo performance.
Advanced dispersion techniques minimize particle aggregation, ensuring uniformity and long-term stability during storage.
We provide comprehensive documentation and testing data to support the preparation and validation of your product, ensuring consistency and reliability throughout development.
From lab-scale development to commercial batch production, we provide consistent, scalable CaHA filler solutions tailored to customer needs.
CaHA fillers are widely classified based on their medical applications, compositional combinations, and functional mechanisms. These categories are designed to meet diverse aesthetic and therapeutic needs, offering customized solutions for volume restoration, contour shaping, collagen stimulation, and long-lasting skin regeneration.
This category uses CaHA microspheres as the core component, offering immediate structural support and sustained collagen stimulation through controlled calcium ion release. The microspheres typically feature optimized size distribution and porous architecture to ensure high elasticity, smooth injection, and long-lasting effects.
These formulations combine hyaluronic acid for immediate volumizing with CaHA microspheres for long-term collagen regeneration. This dual-action system allows for instant aesthetic improvement while supporting gradual tissue remodeling, often used for facial contour refinement and skin texture enhancement.
Surface-modified microspheres or bioactive molecule-loaded formulations are designed to enhance specific properties. Examples include charged microsphere surfaces for improved collagen binding and reduced migration, or the incorporation of growth factors and antimicrobial peptides to broaden applications into wound healing and infection prevention.
CaHA fillers are also tailored to meet the anatomical and mechanical demands of different facial areas. Medium particle sizes and balanced elasticity are ideal for mid-face volumization, while high G’ formulations strengthen jawline definition and lower face sculpting. Small-particle, low-diffusion variants are preferred for delicate zones such as the periorbital area.
At BOC Sciences, the development of CaHA fillers follows a meticulous process, from the careful selection of raw materials to rigorous validation. This process integrates advanced material science, thorough biocompatibility assessments, and scalable production techniques, ensuring the creation of safe, effective, and high-quality fillers.
Using chemical precipitation or hydrothermal synthesis methods, we ensure high purity and biological contamination-free Hydroxyapatite raw materials. The selection of excipients optimizes rheological properties, ensuring the stability and safety of the final product.
Methods such as electrochemical deposition and spray drying are used to create CaHA microspheres with high porosity and strength. High-temperature sintering improves crystallinity and compressive strength, ensuring the product’s physical properties meet the required standards.
By adjusting surface charges and loading biological activity, we enhance microsphere adhesion to tissues and improve their application in bone repair and wound healing, ensuring therapeutic efficacy and safety.
Fibroblast adhesion experiments, degradation simulations, and animal model validations assess the promotion of cell proliferation, degradation rate, and biocompatibility of the microspheres, ensuring both safety and effectiveness of the product.
Key quality indicators such as particle size distribution, endotoxin testing, and mechanical properties are tested to meet industry standards. Additionally, accelerated aging tests and activity retention after reconstitution of lyophilized powder verify the product's stability.
As a dedicated supplier of chemical and biological material solutions, BOC Sciences offers end-to-end raw materials and technical support for the development and production of CaHA fillers. We select high-purity materials to ensure low endotoxin levels and excellent batch-to-batch consistency, covering the full range from active ingredient synthesis to carrier matrix optimization and functional additives. Our solutions help customers efficiently advance both aesthetic and medical-grade filler development. Our offerings include, but are not limited to:
BOC Sciences offers comprehensive manufacturing capabilities for CaHA filler formulations, ensuring high-quality, stable, and traceable products for medical and aesthetic applications. Our production facilities are equipped with advanced reaction systems, sterile processing environments, and automated production lines, supporting smooth scale-up from laboratory development to pilot and commercial-scale batches. Throughout the entire process — from raw material selection and formulation optimization to aseptic manufacturing, quality control, and final packaging — we are committed to maintaining product consistency, safety, and performance. Our flexible production system allows for customized output, ranging from small experimental quantities to bulk commercial supply, tailored to meet the specific needs of each project.
BOC Sciences offers a full suite of analytical services supported by advanced instrumentation to ensure the quality, safety, and performance of CaHA filler formulations. Our capabilities cover every stage of development, from raw material verification to final product validation, helping clients meet stringent product requirements with confidence.
BOC Sciences' CaHA filler formulations extend beyond aesthetic enhancement into regenerative medicine and advanced therapeutic delivery. Their unique physicochemical properties enable multifunctional solutions, offering both immediate structural support and long-term biological integration across diverse medical and cosmetic scenarios.
CaHA filler formulation refers to injectable dermal fillers composed of calcium hydroxylapatite microspheres suspended in a gel carrier. They provide immediate volume restoration and stimulate collagen production, making them ideal for facial contouring, wrinkle correction, and regenerative treatments.
CaHA fillers typically offer long-lasting results ranging from 12 to 18 months, depending on the injection site and patient metabolism. Their dual-action mechanism combines immediate structural support with gradual collagen stimulation for extended aesthetic benefits.
Unlike hyaluronic acid fillers, CaHA fillers offer both immediate volumization and long-term collagen stimulation. CaHA microspheres provide higher mechanical strength and longer-lasting results, making them ideal for deep facial contouring and regenerative medicine applications.
Yes, CaHA fillers are considered safe when formulated with biocompatible ingredients and produced under strict quality controls. Their composition closely mimics natural bone minerals, reducing immune response and supporting long-term tissue integration.
CaHA filler formulation undergoes comprehensive testing including particle size analysis, rheological measurement, endotoxin detection, sterility tests, and mechanical strength assessment to ensure safety, consistency, and performance in medical and cosmetic applications.